Further Collaboration. All interviewees offer further support and collaboration, through developing links, providing support of different kinds, and further participating in the co-design and workshop actions. Main Interview findings Current and Future Needs / Collaboration Group • Collaboration is required primarily for exchange of threat intelligence. • Best form is a “virtual team”, using hosted facilities. • Key roles: platform hosting (maintain database and communication facilities, receive information to share, share information with relevant targets, provide centralised analysis); group collaboration (formation, identifying contact points, participation in sharing). • Technical experts add data from authoritative data sources. • Membership should be IM/RU, with links to DSP and Suppliers Issues around Sharing / Supporting Services • Sharing may have to be anonymised, and trust is critical for team success. • Organisations need to agree what triggers sharing - events and information of interest. • Identified items are alerts (incident or attempt), bulletins (security news), awareness. • Training and exchange of experience can be supported by ISC / ENISA Technical Facilities • Database and communications for holding and sharing security information. • Target technology is MISP since it is already in use in rail. • MISP central instance linked to IM/RU local instances addresses requirements. • Rule-based filters can allow selection of preferred content. • Platform hosting should be secure and tested to ensure control of data Additional Issues • Naming the initiative CSIRT is misleading, ad so new name is required. • Sharing with the XX-XXXX should be formalised
Further Collaboration. Nothing in this Agreement shall prevent Biota from undertaking a collaborative project or entering an agreement with a third party for the purpose of or in relation to the use of Biota IP or Foreground IP in conjunction with the Intellectual Property of such third party to develop one or more diagnostics, provided that in the event Biota enters into a collaboration with a third party and develops and markets an influenza diagnostic in competition to the Diagnostic, BioStar's obligations under clause 7.1 to sell at least the Minimum Sales Volume for each Sales Year shall cease.
Further Collaboration. After the Effective Date, the parties intend to discuss developments of technology related to CADUS Technology and other enhancements of the Research Program. However, the parties are under no obligation to enter into any agreements regarding such developments and enhancements.
Further Collaboration. Both Parties agree to enter good faith discussions regarding a potential further collaboration in the Chinese market, which may include (for example) Product repackaging, assembly and/or manufacturing. Based on the final conclusions of these discussions, the Parties may enter into a separate written agreement regarding the terms and conditions of such further collaboration. Distributor currently performs final packaging operations of RAMP® test cartridges supplied by Response. Response and Distributor wish to discuss expansion of the operations performed by Distributor to include (for example) select manufacturing operations regarding the test cartridge Product.
Further Collaboration. The Pulsar Network allows the distribution of computing jobs from the European Galaxy server across several European data centers. For instance, INFN and XXXX, both involved in EOSC-Pillar, are hosting two Pulsar nodes. The network has already proven to be scalable and reliable, i.e. during the COVID-19 pandemic to run specific bioinformatics workflows (xxxxx://xxxxx00.xxxxxxxxxxxxx.xxx). Nevertheless, data needs to be moved from Galaxy to the computing nodes, which impacts negatively on the job’s execution time in case of large amounts of data. Both projects are interested in developing a distributed caching layer, using already available solutions, like iRODS, to reduce the job staging time for those nodes that already access the required data. With this scientific agreement, we aim at strengthening the collaboration between the two European projects. This text will be presented to both the EOSC-Pillar and the EOSC-Life boards. For the EOSC-Pillar project Xxxxxx Xxxxxxxx (EOSC-Pillar Project Manager, XXXX) xxxxxx.xxxxxxxx@xxxx.xx 13th July 2022 Xxxxxx Xxxxxxxx Digitally signed by Xxxxxx Xxxxxxxx DN: c=IT, st=Roma, l=Roma, o=Consortium XXXX, ou=Dipartimento CSD, cn=Xxxxxx Xxxxxxxx
Further Collaboration. At BAYER's request and under the terms of one or more mutually agreeable separate written agreements, SONTRA is willing to continue to support Bayer’s development of products in the Field of Use.
Further Collaboration. Nothing in this Agreement shall be taken as any form of agreement on the part of either party to enter into further discussions or agreements with the other.
Further Collaboration. Based on what has been achieved so far, the alliance partners have agreed to continue their collaboration. The focus will be on further improving transparency and efficiency in the sector. The partners will be closely examining how communication can be used to raise all stakeholders to the same level of information. In addition, they will study whether projects like a licensing system for all bunker fuel suppliers are feasible, and review the possible international implementation of further quality requirements where necessary. The alliance will also study the impact of new air quality and environmental regulations on the bunkering sector. Moreover, the parties involved are delighted to announce that the KVNR (Royal Dutch Shipowners Association) has joined the alliance – meaning that the users of the bunkering services have now also ‘pulled up a chair’ and the entire chain is presently involved in the consultations. Port of Rotterdam Authority NOVE (Nederlandse Organisatie voor de Energiebranche) VNPI (Vereniging van Nederlandse Petroleum Industrie) VOTOB (Vereniging van Nederlandse Tankopslagbedrijven) KVNR
Further Collaboration. During the period of Research Years, OSI may disclose to FRI, subject to OSI's obligations to Third Parsxx (xxcluding, but not limited to, confidentiality obligations), information concerning technical progress made by OSI in connection with new assay development. If, upon such disclosure by OSI, FRI wishes to enter into a similar research collaboration and license agreement in respect of such now assays, OSI may propose to FRI the terms of such an agreement.
Further Collaboration. The Parties intend to collaborate regarding pre-clinical development of the Assigned Products, including evaluation of the Assigned Products in additional clinical indications. Such collaboration will be pursuant to a separate agreement that will provide for reimbursement of any UMC Mainz costs and resources incurred and committed to such collaboration.
